Antares Pharma (ATRS) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Antares Pharma (ATRS) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 19, 2024 (08:02)

Sector: Healthcare

The share price of Antares Pharma, Inc. (ATRS) now

This company is DELISTED
Latest session on the 7th of September for
Antares Pharma, Inc. is negative
Trading Volume: 6
Open: 5.59 /  High: 5.59 /  Low: 5.59
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Antares Pharma stocks, the 50-day moving average is the support level today.

For Antares Pharma stocks, the 200-day moving average is the support level today.

Are you interested in Antares Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Antares Pharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one Antares Pharma share be worth in 2024 - 2028?

When should I take profit in Antares Pharma stock? When should I record a loss on Antares Pharma stock? What are analysts' forecasts for Antares Pharma stock? What is the future of Antares Pharma stock? We forecast Antares Pharma stock performance using neural networks based on historical data on Antares Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Antares Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Antares Pharma shares. This happens once a day.


Historical and forecast chart of Antares Pharma stock

The chart below shows the historical price of Antares Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Antares Pharma stock price can be found in the table below.

No data

Long-term forecasts by years.

Antares Pharma Inc. (Antares) is a specialized pharmaceutical company specializing in the development and commercialization of independent parenteral pharmaceutical products and technologies. The company designs and manufactures pressurized, needleless and needleless injection devices that allow patients to self-administer medications. The company’s subcutaneous injection technology platforms include VIBEX disposable pressure boosted automatic nozzles, reusable Vision needle-free nozzles, and disposable multifunction manual nozzles. The Company operates through the drug delivery segment, which includes parenteral pharmaceutical products and technologies. The company developed OTREXUP (Methotrexate) Injection, which is a single dose single-use auto-injector.

Antares Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 21 5.62 5.57 5.69 2.10
Jul 22 5.63 5.56 5.69 2.31
Jul 23 5.56 5.53 5.60 1.25
Jul 24 5.46 5.41 5.49 1.56
Jul 25 5.53 5.47 5.61 2.61
Jul 26 5.62 5.60 5.70 1.95
Jul 27 5.61 5.56 5.65 1.53
Jul 28 5.63 5.59 5.67 1.41
Jul 29 5.71 5.68 5.74 1.09
Jul 30 5.72 5.64 5.79 2.60
Jul 31 5.78 5.69 5.80 1.91
Aug 01 5.83 5.78 5.91 2.28
Aug 02 5.82 5.77 5.85 1.31
Aug 03 5.81 5.73 5.88 2.66
Aug 04 5.93 5.85 6.02 2.90
Aug 05 5.87 5.85 5.90 0.86
Aug 06 5.91 5.82 5.96 2.50
Aug 07 5.90 5.82 6.00 3.08
Aug 08 5.80 5.76 5.83 1.19
Aug 09 5.85 5.76 5.91 2.62
Aug 10 5.82 5.77 5.86 1.57
Aug 11 5.76 5.69 5.79 1.70
Aug 12 5.74 5.71 5.78 1.29
Aug 13 5.81 5.76 5.90 2.46
Aug 14 5.80 5.72 5.84 1.99
Aug 15 5.78 5.71 5.85 2.47
Aug 16 5.76 5.69 5.79 1.76
Aug 17 5.70 5.62 5.78 2.90
Aug 18 5.73 5.64 5.81 3.03
Aug 19 5.64 5.57 5.70 2.31

Antares Pharma Daily Price Targets


Antares Pharma Stock Forecast 07-21-2024.

Forecast target price for 07-21-2024: $5.62.
Positive dynamics for Antares Pharma shares will prevail with possible volatility of 2.054%.
Pessimistic target level: 5.57
Optimistic target level: 5.69

Antares Pharma Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $5.63.
Positive dynamics for Antares Pharma shares will prevail with possible volatility of 2.256%.
Pessimistic target level: 5.56
Optimistic target level: 5.69

Antares Pharma Stock Forecast 07-23-2024.

Forecast target price for 07-23-2024: $5.56.
Negative dynamics for Antares Pharma shares will prevail with possible volatility of 1.230%.
Pessimistic target level: 5.53
Optimistic target level: 5.60

Antares Pharma Stock Forecast 07-24-2024.

Forecast target price for 07-24-2024: $5.46.
Negative dynamics for Antares Pharma shares will prevail with possible volatility of 1.531%.
Pessimistic target level: 5.41
Optimistic target level: 5.49

Antares Pharma Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $5.53.
Positive dynamics for Antares Pharma shares will prevail with possible volatility of 2.543%.
Pessimistic target level: 5.47
Optimistic target level: 5.61

Antares Pharma Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $5.62.
Positive dynamics for Antares Pharma shares will prevail with possible volatility of 1.913%.
Pessimistic target level: 5.60
Optimistic target level: 5.70

ATRS (ATRS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 5.72 5.32 6.01 11.61
Sep. 5.84 5.58 6.28 11.06
Oct. 6.07 5.90 6.52 9.62
Nov. 5.95 5.48 6.43 14.85
Dec. 5.56 5.32 5.73 7.04

Antares Pharma forecast for this year


Antares Pharma Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $5.71913. Pessimistic: $5.32. Optimistic: $6.01


Antares Pharma Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $5.84495. Pessimistic: $5.58. Optimistic: $6.28


Antares Pharma Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $6.06998. Pessimistic: $5.90. Optimistic: $6.52


Antares Pharma Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $5.94979. Pessimistic: $5.48. Optimistic: $6.43


Antares Pharma Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $5.55711. Pessimistic: $5.32. Optimistic: $5.73



Antares Pharma (ATRS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 5.51 5.33 5.99 10.93
Feb 6.01 5.86 6.41 8.65
Mar 6.24 6.05 6.59 8.23
Apr 6.21 5.83 6.70 12.94
May 6.08 5.56 6.61 15.87
Jun 5.74 5.43 6.22 12.60
Jul 6.01 5.84 6.36 8.11
Aug 6.11 5.89 6.38 7.68
Sep 5.78 5.28 5.92 10.74
Oct 5.47 5.13 5.82 11.79
Nov 5.52 5.18 5.93 12.68
Dec 5.92 5.56 6.23 10.76

Antares Pharma (ATRS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 6.26 5.95 6.52 8.76
Feb 6.00 5.82 6.38 8.80
Mar 5.77 5.29 6.04 12.39
Apr 5.96 5.76 6.20 6.98
May 6.23 5.78 6.57 11.99
Jun 6.00 5.65 6.18 8.64
Jul 5.96 5.63 6.28 10.33
Aug 5.85 5.50 6.03 8.76
Sep 6.04 5.76 6.52 11.63
Oct 6.70 6.34 7.16 11.52
Nov 6.67 6.24 7.10 12.10
Dec 6.17 5.78 6.42 9.94

Antares Pharma (ATRS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 6.09 5.78 6.36 9.06
Feb 6.41 6.21 6.95 10.66
Mar 6.32 5.99 6.75 11.32
Apr 6.36 5.90 6.67 11.65
May 6.98 6.44 7.44 13.41
Jun 7.01 6.44 7.61 15.40
Jul 7.33 6.85 7.79 12.01
Aug 7.86 7.49 8.24 9.13
Sep 7.71 7.14 8.05 11.38
Oct 7.64 7.13 8.24 13.45
Nov 7.12 6.71 7.38 9.13
Dec 7.19 6.88 7.49 8.24

Antares Pharma (ATRS) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 6.85 6.30 7.39 14.78
Feb 6.48 6.04 6.78 10.83
Mar 6.73 6.16 6.96 11.49
Apr 6.47 6.04 6.63 8.90
May 6.69 6.33 7.07 10.51
Jun 6.72 6.33 7.13 11.29
Jul 7.01 6.78 7.26 6.59
Aug 7.00 6.77 7.34 7.76
Sep 7.57 6.95 7.77 10.51
Oct 7.74 7.28 8.41 13.46
Nov 7.37 6.82 7.57 9.85
Dec 7.76 7.58 8.43 10.12

Antares Pharma information and performance

Antares Pharma Address

N/A

Market Capitalization: N/A $

Market capitalization of the Antares Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ATRS shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Antares Pharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.